Evidence map›Paper›PMID 39548266›Full record

ArticleEMBO reports2025

The Dystrophin-Dystroglycan complex ensures cytokinesis efficiency in Drosophila epithelia.

Margarida Gonçalves, Catarina Lopes, Hervé Alégot, Mariana Osswald, Floris Bosveld, Carolina Ramos, Graziella Richard, Yohanns Bellaiche, Vincent Mirouse, Eurico Morais-de-Sá

Abstract read
In one paragraph

Article in EMBO reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Margarida GonçalvesIBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135, Porto, Portugal.ORCID http://orcid.org/0000-0003-1180-9270
Catarina LopesIBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135, Porto, Portugal.
Hervé AlégotUniversité Clermont Auvergne - iGReD (Institute of Genetics, Reproduction and Development), UMR CNRS 6293 - INSERM U1103, Faculté de Médecine, Clermont-Ferrand, France.
Mariana OsswaldIBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135, Porto, Portugal.
Floris BosveldInstitut Curie, Université PSL, Sorbonne Université, CNRS UMR3215, INSERM U934, Genetics and Developmental Biology, 75005, Paris, France.ORCID http://orcid.org/0000-0002-4733-9074
Carolina RamosIBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135, Porto, Portugal.
Graziella RichardUniversité Clermont Auvergne - iGReD (Institute of Genetics, Reproduction and Development), UMR CNRS 6293 - INSERM U1103, Faculté de Médecine, Clermont-Ferrand, France.
Yohanns BellaicheInstitut Curie, Université PSL, Sorbonne Université, CNRS UMR3215, INSERM U934, Genetics and Developmental Biology, 75005, Paris, France.ORCID http://orcid.org/0000-0003-1686-2943
Vincent MirouseUniversité Clermont Auvergne - iGReD (Institute of Genetics, Reproduction and Development), UMR CNRS 6293 - INSERM U1103, Faculté de Médecine, Clermont-Ferrand, France.ORCID http://orcid.org/0000-0001-5823-342X
Eurico Morais-de-SáIBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135, Porto, Portugal. eurico.sa@ibmc.up.pt.ORCID http://orcid.org/0000-0003-3525-8231

Funding

ATTENTION, COGNITION AND DRIVING PERFORMANCE IN SDATR01AG010145 · NIA · JEWISH HOSPITAL OF SAINT LOUIS · PI MORRIS, JOHN · 1992 to 1994
–
AFM - Telethon MyoNeurAlp2 networkAgence Nationale de la Recherche (ANR) ANR-10-INBS-0Agence Nationale de la Recherche (ANR) TiMecaDiv 20CE13000801Fondation pour la recherche contre le cancer SL220130607097French government IDEX-ISITE initiative 16-IDEX-0001 (CAP 20-25)Institut National du cancer CANCERO-INCA (PLBIO2020/BELLAICHE)IPATIMUP CANCER_CHALLENGE2022MEC | Fundação para a Ciência e a Tecnologia (FCT) CEECIND/00622/2017MEC | Fundação para a Ciência e a Tecnologia (FCT) PTDC/BIA-CEL/1511/2021MEC | Fundação para a Ciência e a Tecnologia (FCT) SFRH/BD/130708/2017MEC | Fundação para a Ciência e a Tecnologia (FCT) UIDB/04293/2020PPBI - Portuguese Platform of Bioimaging PPBI-POCI-01-0145-FEDER-022122
6 · The paper itself

Abstract

Cytokinesis physically separates daughter cells at the end of cell division. This step is particularly challenging for epithelial cells, which are connected to their neighbors and to the extracellular matrix by transmembrane protein complexes. To systematically evaluate the impact of the cell adhesion machinery on epithelial cytokinesis efficiency, we performed an RNAi-based modifier screen in the Drosophila follicular epithelium. Strikingly, this unveiled adhesion molecules and transmembrane receptors that facilitate cytokinesis completion. Among these is Dystroglycan, which connects the extracellular matrix to the cytoskeleton via Dystrophin. Live imaging revealed that Dystrophin and Dystroglycan become enriched in the ingressing membrane, below the cytokinetic ring, during and after ring constriction. Using multiple alleles, including Dystrophin isoform-specific mutants, we show that Dystrophin/Dystroglycan localization is linked with unanticipated roles in regulating cytokinetic ring contraction and in preventing membrane regression during the abscission period. Altogether, we provide evidence that, rather than opposing cytokinesis completion, the machinery involved in cell-cell and cell-matrix interactions has also evolved functions to ensure cytokinesis efficiency in epithelial tissues.

Indexed as

CytokinesisDrosophila melanogasterDrosophila ProteinsDystroglycansDystrophinEpithelial CellsAnimalsEpitheliumRNA InterferenceDrosophila ProteinsDystroglycansDystrophinCell AdhesionCytokinesisDystrophinEpithelial TissuesExtracellular Matrix

Identifiers

PMID39548266
PMCPMC11772804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.